TREVENA INC (TRVN) Fundamental Analysis & Valuation
NASDAQ:TRVN • US89532E2081
Current stock price
2.5 USD
-2.11 (-45.71%)
At close:
2.39 USD
-0.11 (-4.4%)
After Hours:
This TRVN fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. TRVN Profitability Analysis
1.1 Basic Checks
- TRVN had negative earnings in the past year.
- TRVN had a negative operating cash flow in the past year.
- TRVN had negative earnings in each of the past 5 years.
- In the past 5 years TRVN always reported negative operating cash flow.
1.2 Ratios
- With a Return On Assets value of -264.95%, TRVN is not doing good in the industry: 94.16% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -264.95% | ||
| ROE | N/A | ||
| ROIC | N/A |
ROA(3y)-91.28%
ROA(5y)-69.95%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- TRVN has a better Gross Margin (44.36%) than 78.76% of its industry peers.
- TRVN's Gross Margin has declined in the last couple of years.
- The Profit Margin and Operating Margin are not available for TRVN so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 44.36% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-20.92%
GM growth 5YN/A
2. TRVN Health Analysis
2.1 Basic Checks
- TRVN does not have a ROIC to compare to the WACC, probably because it is not profitable.
- Compared to 1 year ago, TRVN has less shares outstanding
- TRVN has a worse debt/assets ratio than last year.
2.2 Solvency
- TRVN has an Altman-Z score of -44.49. This is a bad value and indicates that TRVN is not financially healthy and even has some risk of bankruptcy.
- TRVN has a worse Altman-Z score (-44.49) than 93.98% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | N/A | ||
| Altman-Z | -44.49 |
ROIC/WACCN/A
WACC3.98%
2.3 Liquidity
- TRVN has a Current Ratio of 3.46. This indicates that TRVN is financially healthy and has no problem in meeting its short term obligations.
- With a Current ratio value of 3.46, TRVN is not doing good in the industry: 60.88% of the companies in the same industry are doing better.
- A Quick Ratio of 3.46 indicates that TRVN has no problem at all paying its short term obligations.
- Looking at the Quick ratio, with a value of 3.46, TRVN is in line with its industry, outperforming 41.06% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.46 | ||
| Quick Ratio | 3.46 |
3. TRVN Growth Analysis
3.1 Past
- The earnings per share for TRVN have decreased strongly by -265.62% in the last year.
- The Revenue has grown by 40.93% in the past year. This is a very strong growth!
- TRVN shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -11.42% yearly.
EPS 1Y (TTM)-265.62%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-733.33%
Revenue 1Y (TTM)40.93%
Revenue growth 3Y0.59%
Revenue growth 5Y-11.42%
Sales Q2Q%-89.24%
3.2 Future
- TRVN is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 49.93% yearly.
- The Revenue is expected to grow by 198.34% on average over the next years. This is a very strong growth
EPS Next Y-916.33%
EPS Next 2Y-154.34%
EPS Next 3Y-100.54%
EPS Next 5Y49.93%
Revenue Next Year-95.22%
Revenue Next 2Y63.52%
Revenue Next 3Y-25.99%
Revenue Next 5Y198.34%
3.3 Evolution
- The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. TRVN Valuation Analysis
4.1 Price/Earnings Ratio
- The Price/Earnings Ratio is negative for TRVN. In the last year negative earnings were reported.
- Also next year TRVN is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
- A cheap valuation may be justified as TRVN's earnings are expected to decrease with -100.54% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-154.34%
EPS Next 3Y-100.54%
5. TRVN Dividend Analysis
5.1 Amount
- No dividends for TRVN!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
TRVN Fundamentals: All Metrics, Ratios and Statistics
2.5
-2.11 (-45.71%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)08-08 2024-08-08/bmo
Earnings (Next)11-12 2024-11-12/bmo
Inst Owners4.42%
Inst Owner Change0%
Ins Owners1065.78%
Ins Owner Change0%
Market Cap2.13M
Revenue(TTM)3.65M
Net Income(TTM)-60.79M
Analysts82.5
Price Target102 (3980%)
Short Float %0.39%
Short Ratio0.03
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)34.61%
Min EPS beat(2)24.91%
Max EPS beat(2)44.32%
EPS beat(4)2
Avg EPS beat(4)-95.1%
Min EPS beat(4)-275.05%
Max EPS beat(4)44.32%
EPS beat(8)5
Avg EPS beat(8)-33.77%
EPS beat(12)8
Avg EPS beat(12)-19.49%
EPS beat(16)10
Avg EPS beat(16)-15.67%
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)2400%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-1998.85%
EPS NY rev (1m)0%
EPS NY rev (3m)-2027.39%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)1500%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 0.58 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | N/A | ||
| P/tB | N/A | ||
| EV/EBITDA | N/A |
EPS(TTM)-16.38
EYN/A
EPS(NY)-20.25
Fwd EYN/A
FCF(TTM)-37.1
FCFYN/A
OCF(TTM)-37.08
OCFYN/A
SpS4.29
BVpS-22.3
TBVpS-22.3
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -264.95% | ||
| ROE | N/A | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 44.36% | ||
| FCFM | N/A |
ROA(3y)-91.28%
ROA(5y)-69.95%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-20.92%
GM growth 5YN/A
F-Score3
Asset Turnover0.16
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 6.16% | ||
| Cap/Sales | 0.58% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 3.46 | ||
| Quick Ratio | 3.46 | ||
| Altman-Z | -44.49 |
F-Score3
WACC3.98%
ROIC/WACCN/A
Cap/Depr(3y)8.27%
Cap/Depr(5y)6.21%
Cap/Sales(3y)3.99%
Cap/Sales(5y)2.59%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-265.62%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-733.33%
EPS Next Y-916.33%
EPS Next 2Y-154.34%
EPS Next 3Y-100.54%
EPS Next 5Y49.93%
Revenue 1Y (TTM)40.93%
Revenue growth 3Y0.59%
Revenue growth 5Y-11.42%
Sales Q2Q%-89.24%
Revenue Next Year-95.22%
Revenue Next 2Y63.52%
Revenue Next 3Y-25.99%
Revenue Next 5Y198.34%
EBIT growth 1Y-46.03%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y41.56%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y41.58%
OCF growth 3YN/A
OCF growth 5YN/A
TREVENA INC / TRVN Fundamental Analysis FAQ
Can you provide the ChartMill fundamental rating for TREVENA INC?
ChartMill assigns a fundamental rating of 2 / 10 to TRVN.
What is the valuation status of TREVENA INC (TRVN) stock?
ChartMill assigns a valuation rating of 0 / 10 to TREVENA INC (TRVN). This can be considered as Overvalued.
What is the profitability of TRVN stock?
TREVENA INC (TRVN) has a profitability rating of 1 / 10.
What is the expected EPS growth for TREVENA INC (TRVN) stock?
The Earnings per Share (EPS) of TREVENA INC (TRVN) is expected to decline by -916.33% in the next year.